Report post
Pfizer has finalized its $43 billion acquisition of cancer drug Maker Seagen. The deal marks Pfizer's latest move in expanding its healthcare portfolio. The company is also reportedly in early talks to acquire other firms, while Pfizer CEO weighs in on the sales potential of its MRNA weight loss drug. Stay tuned for updates on Pfizer's business strategy and future acquisitions.

The World's Leading Crypto Trading Platform

Get my welcome gifts